(Q39996141)

16 September 2017

1 reference

title

Factor VIII (Anti-hemophilic factor) (English)

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

20 March 2023

main subject

hemophilia

0 references

Coagulation factor VIII

0 references

author name string

D. Green

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:4925082

20 March 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4925082

20 March 2023

publication date

1 October 1970

1 reference

full work available at URL

16 September 2017

https://api.elsevier.com/content/article/PII:0021968170950020?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

https://api.elsevier.com/content/article/PII:0021968170950020?httpAccept=text/plain

20 March 2023

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Journal of Chronic Diseases

20 March 2023

published in

1 reference

16 September 2017

volume

23

1 reference

16 September 2017

issue

4

1 reference

16 September 2017

page(s)

213-225

1 reference

On a Method of Determining the Condition of Blood Coagulability for Clinical and Experimental Purposes, and on the Effect of the Administration of Calcium Salts in Haemophilia and Actual or Threatened Haemorrhage: [Preliminary Communication]

16 September 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

HEMOPHILIA. II. SOME PROPERTIES OF A SUBSTANCE OBTAINED FROM NORMAL HUMAN PLASMA EFFECTIVE IN ACCELERATING THE COAGULATION OF HEMOPHILIC BLOOD.

20 March 2023

3

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

The thromboplastin generation test

20 March 2023

4

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Experiments with factor 8 separated from fibrinogen by electrophoresis in free buffer film

20 March 2023

5

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

ANTIHAEMOPHILIC FACTOR (FACTOR VIII): AN ALPHA-2 GLOBULIN

20 March 2023

9

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Production of High-Potency Concentrates of Antihemophilic Globulin in a Closed-Bag System

20 March 2023

10

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

PURIFICATION OF ANTIHEMOPHILIC FACTOR (FACTOR VIII) BY AMINO ACID PRECIPITATION

20 March 2023

12

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Human antihemophilic factor (AHF) purification: A comparison of two procedures

20 March 2023

15

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

The purification of factor 8 (antihaemophilic globulin). II. Further purification and some properities of factor 8

20 March 2023

17

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Further studies on the inheritance of factor 8

20 March 2023

18

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Plasma Antihæmophilic-Factor Concentrations in the Australian Aborigine and in Conditions associated with Hyperglobulinæmia

20 March 2023

19

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Blood Coagulation and Fibrinolysis in Relation to Coronary Heart Disease

20 March 2023

20

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Assay of antihaemophilic globulin in treatment of haemophilic patients

20 March 2023

21

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Biological Half-Life of Transfused Antihaemophilic Globulin (Factor VIII) In Normal Man

20 March 2023

22

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Reaction Sequence of Blood Coagulation

20 March 2023

25

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Sequence Theories of Blood Coagulation re-evaluated with reference to Lipid–Protein Interactions

20 March 2023

26

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

THROMBIN AND THE INTERACTION OF FACTORS 8 AND 9.

20 March 2023

27

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

THE FACTOR-8 CONCENTRATION OF THE HEPATIC VENOUS BLOOD

20 March 2023

29

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Hemophilia: role of organ homografts

20 March 2023

30

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Hepatic Influence on Splenic Synthesis and Release of Coagulation Activities

20 March 2023

31

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Kidney antihemophilic factor. Partial purification and some properties

20 March 2023

35

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Increase in antihaemophilic globulin activity following infusion of adrenaline

20 March 2023

43

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Effect of exercise on the level of antihaemophilic globulin in human blood

20 March 2023

44

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Alterations of fibrinolysis and blood coagulation induced by exercise, and the role of beta-adrenergic-receptor stimulation.

20 March 2023

48

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Blood Coagulation in Thyroid Dysfunction

20 March 2023

49

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Effects of Corticosteroids on Coagulation of the Blood

20 March 2023

50

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Effect of corticosteroids on factor VIII level

20 March 2023

51

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

ELEVATION OF FACTOR VIII (ANTIHEMOPHILIC FACTOR) DURING PREGNANCY IN NORMAL PERSONS AND IN A PATIENT WITH VON WILLEBRAND'S DISEASE

20 March 2023

52

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Oral Contraception and Blood Coagulability

20 March 2023

53

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Increased Factor VIII Levels in Suspected Carriers of Hemophilia A Taking Contraceptives by Mouth

20 March 2023

54

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

CNS influence on plasma levels of factor 8 activity

20 March 2023

55

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Gene action in the X-chromosome of the mouse (Mus musculus L.)

20 March 2023

59

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Hemophilia in the First Year of Life

20 March 2023

61

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Myeloperoxidasis and genetics of haemophilia A.

20 March 2023

62

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Widening the scope of antenatal diagnosis.

20 March 2023

63

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Practical and theoretical implications of fetal-maternal lymphocyte transfer

20 March 2023

65

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Autosomal factor-VIII deficiency

20 March 2023

67

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

von Willebrand's disease: A comparative studyof diagnostic tests

20 March 2023

68

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

VON WILLEBRAND'S DISEASE: USE OF A PLATELET-ADHESIVENESS TEST IN DIAGNOSIS AND FAMILY INVESTIGATION

20 March 2023

69

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Transfusion Studies in von Willebrand's Disease: Effect on Bleeding Time and Factor VIII

20 March 2023

70

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

The treatment of haemorrhage in von Willebrand's disease and the blood level of factor VIII (AHG)

20 March 2023

71

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Hemophilia A: polymorphism detectable by a factor 8 antibody

20 March 2023

77

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

20 March 2023

2 forms of haemophilia?

78

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Changes in the blood coagulation system associated with septicemia

20 March 2023

86

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

The hemorrhagic disorders

20 March 2023

87

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Effect of plasmin in vitro on clotting factors in plasma

20 March 2023

88

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

20 March 2023

Fibrinolysis

89

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Acquired hemophilia due to a circulating anticoagulant. Report of two cases, with review of the literature

20 March 2023

90

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Antibody nature of the inhibitor to antihaemophilic globulin (Factor 8).

20 March 2023

92

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

The immunologic character of acquired inhibitors of antihemophilic globulin (factor 8) and the kinetics of their interaction with factor 8.

20 March 2023

93

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

A method for the study of antihaemophilic globulin inhibitors with reference to six cases

20 March 2023

95

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

A method for the study of antihaemophilic globulin inhibitors with reference to six cases

20 March 2023

96

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Acquired circulating anticoagulants in hemophilia A.

20 March 2023

98

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Acquired circulating anticoagulants in hemophilia A.

20 March 2023

99

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Hypercoagulability in acute pancreatitis

20 March 2023

102

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

The concentration of antihemophilic globulin (AHG) in patients with coronary artery disease

20 March 2023

104

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Blood coagulation in renal failure

20 March 2023

107

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Hypercoagulability associated with malignant disease and with the postoperative state. Evidence for elevated levels of antihemophilic globulin

20 March 2023

108

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Comparative Studies of Blood Coagulation and Platelet Aggregation in Patients with Cancer and Nonmalignant Diseases

20 March 2023

109

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Antihaemophilic globulin (AHG) in multiple myeloma and macroglobulinaemia

20 March 2023

112

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Factor-8 (antihaemophilic factor) activity in sickle-cell anaemia

20 March 2023

114

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Blood coagulation and intravascular hemolysis

20 March 2023

115

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

HYPOFIBRINOGENEMIC HEMORRHAGE IN ACUTE MYELOGENOUS LEUKEMIA TREATED WITH HEPARIN. WITH AUTOPSY FINDINGS OF WIDESPREAD INTRAVASCULAR CLOTTING

20 March 2023

117

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

The Role of Intravascular Haemolysis and the Reticulo-Endothelial System in the Production of a Hypercoagulable State

20 March 2023

118

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Atherosclerosis in a haemophiliac

20 March 2023

120

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

Myocardial infarction in a patient with a circulating anticoagulant

20 March 2023

121

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

The role of the liver in serum-induced hypercoagulability

20 March 2023

123

1 reference

https://api.crossref.org/works/10.1016/0021-9681(70)95002-0

20 March 2023

Identifiers

1 reference

16 September 2017

1 reference